Table 2.

Summary of RA patients for whom analysis IL-17-positive CD4 T cells in the blood was conducted

RA patients (n)	44
Age, years (median (IQR))	56 (50 to 65.5)
Sex, female (n)	28
Disease duration, years (median (IQR))	3.5 (1.0 to 5.5)
RF positive (n)	32
ACPA positive (n)	30
ESR, mm/hr (median (IQR))	24 (10 to 40)
CRP, mg/ml (median (IQR))	11 (<5 to 23)
DAS28 (ESR) (median (IQR))	5.15 (4.01 to 6.17)
% IL17-positive CD4 T cells (median (IQR))	1.08 (0.60 to 1.64)
% IL17-positive CD45RO CD4 T cells (median (IQR))	1.10 (0.47 to 1.79)

IQR, interquartile range.